3. 2022 EAU A0958: A nationwide study on the added value of (neo)adjuvant ADT in addition to modern dose-escalated external beam radiotherapy in men with high-risk localized prostate cancer 4. 2022 ESMO LBA9 - Durat...
[1] 2022 ESMO- LBA9 - Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031). [2] Mottet, N., et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Arnhem: European ...
[1] 2022 ESMO- LBA9 - Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031). [2] Mottet, N., et al. EAU-...
External beam radiotherapy (EBRT) is a well-established definitive therapeutic approach for clinically localized prostate cancer (CLPCa). Although CLPCa had been mainly treated with EBRT alone, androgen deprivation therapy (ADT) has been shown to improve not only biochemical control but also survival...
treated with goserelin combined with enzalutamide for 3 months, and PSMA-PET CT: prostate size was normal, no significant68Ga PSMA uptake was increased, no abnormally high Ga PSMA uptake in bones. The patient was treated with enzalutamide combined with ADT as neoadjuvant endocrine therapy, winning...
[1] 2022 ESMO- LBA9 - Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031). [2] Mottet, N., et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Arnhem: European...
[5] Noel W. Clarke, et al.Final overall survival (OS) in PROpel: Abiraterone (abi) and olaparib (ola) versus abiraterone and placebo (pbo) as first-line (1L) therapy for metastatic castration-resistant prostate cancer (mCRPC).Journal of Clinical Oncology.Volume 41, Number 6_suppl ...
104 Orgasm in Men on Androgen Deprivation Therapy (ADT) for Prostate Cancerdoi:10.1016/j.jsxm.2016.02.111Mazzola, C.Teloken, P.E.Matsuhsita, K.Nelson, C.J.Mulhall, J.P.Elsevier Inc.Journal of Sexual Medicine
[2]. 2021 AUA-PD08-09: Meta-analysis of radiation therapy and androgen deprivation therapy in localized prostate cancer. [3]. 2021 AUA-PD34-02: The key role of PSA doubling time in patients treated with salvage radiation therapy after radical prostatectomy: implications for the extent of radi...
5061 Background: The role of ADT for men with node positive prostate cancer following radical prostatectomy (RP) is unclear. One randomized trial has shown a survival advantage for men treated with immediate adjuvant (adj) ADT compared treatment at onset of clinical metastases. However, benefit of...